| Fe3O4
|
β-CD |
Alanine (Ala), Trp, tyr |
Optical polarimetry |
β-CD modified Fe3O4 nanoparticles mostly absorbed (l)-Trp more than (d)-Trp |
68
|
| Fe3O4/SiO2
|
Carboxymethyl-β-CD (CM-β-CD) |
Tryptophan (Trp), phenylalanine (Phe), tyrosine (Tyr) |
UV-vis |
Qualitatively the resolution predicts from the absorption capacity: (l)-Trp > (l)-Phe > (l)-tyr and (d)-Trp > (d)-Phe > (d)-tyr |
69
|
| GO/Fe3O4
|
β-CD |
Trp |
OT-CE |
Av size about 8 nm. Trp enantiomers resolution was 1.65 and was achieved within 50 s |
70
|
| Fe3O4-PS |
Helical substituted polyacetylene |
1-Phenylethylamine |
Optical rotation measurement |
Adsorption of the (R)-form was much higher than the (S)-form of 1-phenylethylamine, e.g., 24.60% at 12 h, compared to 1.76% |
76
|
| Fe3O4/SiO2
|
CM-β-CD |
Trp, Phe, Tyr |
HPLC-UV |
ee for separation (d,l)-Trp, (d,l)-Phe, and (d,l)-Tyr racemic were 94%, 73%, and 58%, respectively |
71
|
| Fe3O4/SiO2
|
Amine functionalized derivatives β-CD (AmCD) |
N-(3,5-Dinitrobenzoyl) phenlglycine, N-(1-phenylethyl) phthalamic acid |
HPLC-UV |
Am-CD-MNPs preferred to adsorb (S)-form enantiomer, i.e., about 50% for (S)-phenylglycine and 30% for (S)-phthalamic acid, while the (R)-form was not carried |
72
|
| Fe3O4
|
BSA |
Ibuprofen, ofloxacin |
HPLC-UV |
Av size ∼13.3 nm. At single-stage operation, ee value of racemic ibuprofen and ofloxacin was 13% and 14%, respectively. The multistage process enhances the ee value up to 54% and 39%, respectively |
81
|
| GO/Fe3O4
|
BSA |
Trp, threonine, propranolol |
OT-CE |
Rs of Trp, threonine, and propranolol were 1.22, 1.9, and 2.1, respectively |
82
|
| Fe3O4@Au |
BSA |
Tryptophan, threonine, ofloxacin |
MCE |
The size of Fe3O4 NPs and Fe3O4@Au NPs were about 8–10 nm and 25–30 nm, and the thickness of the Au shell was 9 nm. Rs were 1.67 (Trp). 1.79 (threonine) and 2.15 (ofloxacin) |
83
|
| Fe3O4@SiO2@PAMAM |
BSA |
Tryptophan, phenylalanine, histidine |
HPLC-PDA |
The mean diameter of Fe3O4 was 400 nm, thickness silica layer was 60 nm. BSA–PMNPs gave stronger interactions the (−)-enantiomers than the (+)-enantiomers |
84
|
| Fe3O4@SiO2@PAMAM |
HSA |
Trp, warfarin, ibuprofen |
CD and CE |
Av diameter of a core–shell structure was 600 nm. HSA–PMSM preferred to interact with the (−)-enantiomers than (+)-enantiomers for (d,l)-Trp and warfarin. In contrast, ibuprofen was the other way around |
85
|
| Fe3O4/SiO2
|
Cationic β-CD |
Dansyl (d,l)-valine, dansyl (d,l)-leucine, dansyl (d,l)-phenylalanine |
CE |
Av particle size was about 580 nm. Cationic-β-CD-modified Fe3O4/SiO2 interacted better with the (l)-enantiomer. Enantiomeric excess for Phe, Leu, and Val are 12.3, 10.0, and 9.6, respectively |
73
|
| Fe3O4/SiO2
|
Maleic anhydride-β-CD (MAH-β-CD) |
Trp, Phe, 2-phenylglycine, chlorpheniramin |
CE |
Av. size of 550 nm. MAH-β-CD-modified Fe3O4 microspheres interacted better with (−)-enantiomers than (+)-enantiomers. It was obtained ee of 12.6% and 13.7% for enantioseparation of (d,l)-trp and chlorpheniramine, respectively |
74
|
| Fe3O4@PDA |
MIP |
Tryp, tyrosine, Gly–Phe, ofloxacin |
OT-CE |
Fe3O4@PDA NPs have an average diameter of 146 nm. ∼8 nm in thickness of MIP. The resolution factor was about 1.65, 1.76, 3.15, and 2.16 for (d,l)-Trp, (d,l)-tyrosine, Gly- (d,l)-Phe, and racemic ofloxacin, respectively |
126
|
| Fe3O4
|
Helical substituted polyacetylene |
Alanine |
SEM, XRD, CD spectra |
(R)-PSA-based microspheres give strong interaction to (d)-ala with an ee of 79%. Whereas (S)-PSA-based microspheres is the other way around with the ee of 62% |
78
|
| Fe3O4
|
Helical substituted polyacetylene |
Alanine |
SEM, XRD, CD spectra |
After three rounds of enantioselective crystallization, the obtained ee is up to 89% |
79
|
| Fe3O4/SiO2
|
β-CD-epichlorohydrin polymers (β-CD-EP) |
Trp |
CE |
β-CD-EP-modified Fe3O4 absorbs more (l)-Trp. The supernatant ee of (d,l)-Trp reached up to 44.2% after interaction with 300 mg of β-CDEP-modified Fe3O4
|
127
|
| iFe3O |
Metal–organic frameworks (MOFs) i.e. [Zn2(bdc)(l-lac)(dmf)](DMF), (ZnBLD) |
Phenyl methyl sulfoxide, phenyl vinyl sulfoxide, 4-chlorophenyl methyl sulfoxide |
HPLC |
The best ee was obtained for the separation of phenyl methyl sulfoxide, e.g., 85.2% |
128
|
| Fe3O4@PNE (polynorepinephrine) |
MIP |
Tryptophan, valine, threonine, Gly–Phe, ofloxacin, binaphthol |
PDMS microchip device |
Particle diameter size is 100 nm on average. PNE coats NPs in 6 nm of thickness. For trp, val, thre, ofloxacin, Gly-(d,l)-Phe, and binaphthol obtained Rs of 1.84, 1.54, 2.17, 3.33, 3.53, and 1.66, respectively |
77
|
| Fe3O4
|
Helical substituted polyacetylene |
Threonine |
SEM, XRD, CD spectra |
The complex particles mostly induced (l)-threonine to form rectangular-shaped crystals with an ee up to 90% after two times of enantioselective crystallization |
80
|
| Fe3O4@SiO2
|
Chiral amino acid ionic liquid, HMDI-EMIMLpro |
Cysteine (Cys), arginine (Arg), leucine (Leu), glutamine (Glu), tryptophan (Trp) |
Automatic digital polarimeter and centrifugal chiral chromatography |
Av diameter of the cluster was 80 nm with average nanoparticles size of about 13 nm. Fe3O4@SiO2@HMDI-EMIMLpro nanospheres preferred to interact with the (+)-enantiomers than that with the (−)-enantiomers cys, arg, and glu. Whereas for Leu and Trp is the other way around |
129
|
| Fe3O4@SiO2
|
Cellulose-2,3-bis(3,5-dimethylphenylcarbamat) (CBDMPC) |
Benzoin methyl ether, promethazine hydrochloride, (±)-2-phenoxypropinionic acid, 4-phenyl-1,3-dioxane, dl-sec-phenethyl alcohol |
Automatic digital polarimeter |
The mean diameter of Fe3O4@SiO2@CBDMPC was 545 ± 20 nm. Fe3O4@SiO2@CBDMPC preferred to interact with the (−)-isomer than the (+)-isomer |
130
|
| Fe3O4@SiO2
|
CBDMPC |
Benzoin |
Chiral microsphere magnetic chromatography |
The mean diameter of the microspheres was 240 ± 20 nm. (l)-benzoin has a high affinity to the chiral selector. The Rs is 1.5 |
131
|
| Fe3O4@ZrO3
|
Cellulose tris(3,5-dimethylphenylcarbamate) (CDMPC) |
Propronolol, alprenolol, pindolol, metoprolol, atenolol, carvedolol, ibuprofen, ketoprofen |
Automatic Polarimeter |
The average particle size is 340 nm. The synthesized particle preferred to bind with (−)-enantiomer of propronolol, alprenolol, pindolol, metoprolol, and atenolol. It is the other way around for carvedolol, ibuprofen, and ketoprofen |
132
|
| Fe3O4
|
Cellulose tris-(4-methylbenzoate) (CTMB) |
Ibuprofen |
HPLC |
Fe3O4@CTMB interacted stronger with the (S)-enantiomer than the (R)-enantiomer of ibuprofen. At the single stage, ee was 4.7%. At four steps, the ee was 26.3% |
89
|
| TiO2@SiO2
|
Cellulose tris(3,5-dimethylphenylcarbamate) (CDMPC) |
Eight basic indole ring derivatives |
HPLC |
From eight indole rings compound, at optimized conditions, only two obtained Rs > 1.5. The best Rs up to 2.89 was achieved |
90
|
| TiO2@SiO2
|
(CDMPC) |
2-Hydroxyl-phenylacetonitrile, α-phenylethanol, matalaxyl, and diclofop-methyl |
HPLC |
Chromatogram shows qualitatively CSP could separate 2-hydroxyl phenylacetonitrile and α phenylethanol well. Rs matalaxyl up to 3.75. RS diclofopmethyl up to 1.67 |
91
|
| SCMNSs (silica-coated magnetite nanospheres) |
Bovine hemoglobin |
Tryptophan |
Spectrofluorometric |
Av size of nanospheres (Hb-SCMNSs) was about 94 nm, with the thickness of the coating layer being about 29 nm. Hb-SCMNSs effectively adsorb the (l)-trp in the presence of (d)-Trp |
86
|
| SCMNSs |
Tryptophan |
Naproxen and phenylglycine |
Resonance light scatterings measurements |
Av diameter of Try-SCMNSs was 130 nm. –MNSs are very sensitive towards + NAP and +PHY enantiomers and, on the other way around |
88
|
| MNPs, i.e., hydroxyl group-modified superparamagnetic nanospheres |
MIP |
Ofloxacin |
Microfluidic channel |
The Av diameter of nanoparticles was 200 nm. The obtained Rs of ofloxacin was 1.46 |
133
|
| Mesoporous silica-coated MNPs (MSMNPs) |
Teicoplanin |
(d,l)-Tryptophan, (d,l)-phenylalanine, (d,l)-mandelic acid, (d,l)-1-phenyl-1,2-ethanediol, N-benzoyl-(d,l)-alanine |
CE |
Av diameter was about 600 nm, and the mean pore size was 3.9 nm. Optical purity for Trp, Phe, MA, Phe-e, and benzoyl-ala was obtained at 35.4, 27.8, 8.0, 13.7, and 34.2%, respectively |
87
|
| MSNPs |
(R)- and (S)-N-(2,2-dimethyl-4-pentanoyl)-proline-3,5-dimethylanilide |
N-(3,5-Dinitrobenzoyl)alanine, valine and leucine, N-propylamide |
HPLC-UV |
Av size MSNPs: 300 nm. (S)-enantiomer was preferred to adsorb by MSNPs/(S)-CS. The ee using MSNPs/(S)-CS was 38.2% in (S) for ala, 29.3% in (S) for Val, and 13.8% in (S) for Leu. Whereas for propylamide, the Rs using MSNPs/(S)-CS was 68.1% ee in (S) and using NMSPs/(R)-CS 80.1% ee in (R) |
134
|